Epstein-Barr virus-associated Hodgkin's disease following renal transplantation
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, Jung-Hye | - |
dc.contributor.author | Ahn, Myung-Ju | - |
dc.contributor.author | Oh, Young-Ha | - |
dc.contributor.author | Han, Sang-Woong | - |
dc.contributor.author | Kim, Ho-Jung | - |
dc.contributor.author | Lee, Young-Yeul | - |
dc.contributor.author | Kim, In-Soon | - |
dc.date.accessioned | 2022-12-21T11:50:38Z | - |
dc.date.available | 2022-12-21T11:50:38Z | - |
dc.date.created | 2022-09-16 | - |
dc.date.issued | 2006-03 | - |
dc.identifier.issn | 1226-3303 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/181683 | - |
dc.description.abstract | Post-transplant lymphoproliferative disorders (PTLD) have been recognized as a complication of immunosuppression and occur with a reported incidence of 1 to 8% of recipients receiving solid organ transplantation. PTLD are classified into two major categories, polymorphic and monomorphic PTLD. The majority of the monomorphic PTLD cases are non-Hodgkin's lymphoma of B-cell origin. Hodgkin's disease is not part of the typical spectrum of PTLD; however, it has been rarely reported. We describe a case of Hodgkin's disease following renal transplantation. A 41-year-old man developed right cervical lymphadenopathy following renal transplantation 116 months previously for chronic renal failure of unknown origin. He had been taking cyclosporine, mycophenolate mofetil and prednisone. A lymph node biopsy revealed mixed cellularity Hodgkin's disease. Immunohistochemical staining was positive for CD30 and EBV-latent membrane protein-1. No other site of disease was identified. The immunosuppressive agents were reduced (mycophenolate mofetil was discontinued, cyclosporine dose reduced from 200 mg to 150 mg and prednisone continued at 5 mg). After 2 cycles of ABVD followed by radiation therapy (3600 cGy), he achieved complete remission. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | Korean Association of Internal Medicine | - |
dc.title | Epstein-Barr virus-associated Hodgkin's disease following renal transplantation | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, Jung-Hye | - |
dc.contributor.affiliatedAuthor | Oh, Young-Ha | - |
dc.contributor.affiliatedAuthor | Han, Sang-Woong | - |
dc.identifier.doi | 10.3904/kjim.2006.21.1.46 | - |
dc.identifier.scopusid | 2-s2.0-33646690485 | - |
dc.identifier.bibliographicCitation | Korean Journal of Internal Medicine, v.21, no.1, pp.46 - 49 | - |
dc.relation.isPartOf | Korean Journal of Internal Medicine | - |
dc.citation.title | Korean Journal of Internal Medicine | - |
dc.citation.volume | 21 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 46 | - |
dc.citation.endPage | 49 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001181119 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.description.journalRegisteredClass | other | - |
dc.subject.keywordPlus | bleomycin | - |
dc.subject.keywordPlus | CD30 antigen | - |
dc.subject.keywordPlus | cyclosporin | - |
dc.subject.keywordPlus | dacarbazine | - |
dc.subject.keywordPlus | doxorubicin | - |
dc.subject.keywordPlus | membrane protein | - |
dc.subject.keywordPlus | mycophenolic acid 2 morpholinoethyl ester | - |
dc.subject.keywordPlus | prednisone | - |
dc.subject.keywordPlus | vinblastine | - |
dc.subject.keywordPlus | adult | - |
dc.subject.keywordPlus | article | - |
dc.subject.keywordPlus | cancer combination chemotherapy | - |
dc.subject.keywordPlus | cancer radiotherapy | - |
dc.subject.keywordPlus | cancer regression | - |
dc.subject.keywordPlus | case report | - |
dc.subject.keywordPlus | cervical lymphadenopathy | - |
dc.subject.keywordPlus | chronic kidney failure | - |
dc.subject.keywordPlus | computer assisted emission tomography | - |
dc.subject.keywordPlus | drug dose reduction | - |
dc.subject.keywordPlus | drug withdrawal | - |
dc.subject.keywordPlus | Epstein Barr virus | - |
dc.subject.keywordPlus | Hodgkin disease | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | human cell | - |
dc.subject.keywordPlus | human tissue | - |
dc.subject.keywordPlus | immune deficiency | - |
dc.subject.keywordPlus | immunohistochemistry | - |
dc.subject.keywordPlus | immunosuppressive treatment | - |
dc.subject.keywordPlus | kidney transplantation | - |
dc.subject.keywordPlus | lymph node biopsy | - |
dc.subject.keywordPlus | male | - |
dc.subject.keywordAuthor | Hodgkin&apos | - |
dc.subject.keywordAuthor | s disease | - |
dc.subject.keywordAuthor | Post-transplant lymphoproliferative disorder | - |
dc.subject.keywordAuthor | Renal transplantation | - |
dc.identifier.url | https://www.kjim.org/journal/view.php?doi=10.3904/kjim.2006.21.1.46 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.